Results 11 to 20 of about 9,117 (217)

Clinical evaluation of Graves ophthalmopathy [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2012
Introduction. Graves ophthalmopathy is an autoimmune disease, which is the consequence of thyroid dysfunction. Ocular manifestations occur in 50% of patients with Graves disease.
Janićijević-Petrović Mirjana A., Šarenac Tatjana, Srećković Sunčica, Janićijević Katarina, Petrović Marko, Vulović Dejan   +5 more
doaj   +4 more sources

Quantitative MRI Assessment of Orbital Structures in Radioactive Iodine-131 Therapy for Inactive Graves' Ophthalmopathy. [PDF]

Int J Endocrinol
Objective The understanding regarding the role of orbital magnetic resonance imaging (MRI) in predicting the prognosis of radioactive iodine‐131 (I‐131) therapy for patients with inactive Graves’ ophthalmopathy (GO) is limited. Therefore, this study aimed to explore the application of MRI quantitative measurements of orbital structures in radioactive I‐
Wang M, Shen ZY, Wu XW.
europepmc   +2 more sources

TSHR-Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition. [PDF]

Adv Sci (Weinh)
This study presents YC3, a novel inhibitory TSHR‐targeting aptamer, as a promising therapeutic for Graves' ophthalmopathy (GO). YC3 suppresses pathological phenotypes in human orbital fibroblasts and improves outcomes in GO mice by binding to a previously unidentified allosteric site on TSHR, demonstrating the potential of aptamers in advancing ...
Zhang Y, Wu E, Liu W, Zeng L, Ling N, Wang H, Li Z, Yao S, Pan T, Li X, Huang Y, Li X, Tu Y, Yan W, Wu J, Ye M, Wu W.   +16 more
europepmc   +2 more sources

Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease [PDF]

, 1996
To date, it has remained unclear whether T cells infiltrating thyroid, retroorbital, and pretibial tissue of patients with Graves' ophthalmopathy and pretibial dermopathy represent a primary immune response that is directed against certain antigenic ...
Heufelder, Armin E., Scriba, Peter C., Wenzel, Björn E.   +2 more
core   +1 more source

Prognostic indicators for the development of strabismus among patients with graves’ ophthalmopathy

Journal of Clinical & Translational Endocrinology, 2017
Objective: Thyroid eye disease (TED), an autoimmune inflammatory process involving the orbital tissues around the eye, is the most common extra-thyroidal manifestation of Graves’ disease (GD). Due to changes in the patient’s appearance, TED is a socially
Tiffany Y. Lin, Ning Li, Michael W. Yeh, Angela M. Leung, Daniel B. Rootman   +4 more
doaj   +1 more source

Graves' ophthalmopathy [PDF]

, 2009
A 40-year-old woman who recently received a diagnosis of Graves' disease comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg daily, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms ...
Bartalena, Luigi, Tanda, Maria Laura Piera   +1 more
core   +1 more source

HUBUNGAN FAKTOR RISIKO TERHADAP KEJADIAN OPHTHALMOPATHY GRAVES

Jurnal Kedokteran Diponegoro, 2019
Latar Belakang: Opthalmopathy Graves merupakan salah satu tanda adanya penyakit Graves; penyakit autoimun dengan inflamasi sistemik. OG bisa terjadi pada penyakit Graves yang fungsi tiroidnya hipertiroidisme, eutiroidisme dan hipotiroidisme.
Y. Andressa Nugroho W., Charles Limantoro, A. Kentar Arimadyo   +2 more
doaj   +1 more source

The thickness of the retrobulbar portion of the optic nerve in Graves ophthalmopathy measured by ultrasound [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2009
Introduction. The clinical diagnostic of Graves ophthalmopathy is based on the association of ocular signs and the disease of the thyroid gland. The evolution of the disease involves the development of eye globe protrusion, extraocular muscle thickening ...
Stefanović Ivan, Paović Jelena, Kovačević Igor, Paović Predrag   +3 more
doaj   +1 more source

Inactive Graves' ophthalmopathy and self-esteem [PDF]

, 2008
PURPOSE: To assess the self-esteem of Graves' ophthalmopathy patients in the inactive phase. METHODS: Thirty euthyroid patients were evaluated in the inactive phase of disease with age ranging from 26 to 65 years, average of 43 ± 11,0 years, called study
Ferreira, Lydia Masako, Magalhães, Carlos Henrique de Toledo, Manso, Paulo Góis, Novo, Neil Ferreira, Pereira, Max Domingues, Veiga, Daniela Francescato   +5 more
core   +2 more sources

Comparative evaluation of oculometric variables in graves' ophthalmopathy

Clinics, 2009
OBJECTIVES: To estimate oculometric parameters of Graves' ophthalmopathy in comparison to healthy eyes using digital photography and digital image analysis. INTRODUCTION: Graves' ophthalmopathy is the main cause of eye proptosis.
Hélio Amante Miot, Leonardo Parr dos Santos Fernandes, Edson Nassib Jorge, Daniel Rosito Pivotto, Célia Regina Nogueira, Gláucia Maria Ferreira da Silva Mazeto   +5 more
doaj   +1 more source